Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dynalabs is a U.S.-based analytical and microbiological testing laboratory serving pharmacies, hospitals, and pharmaceutical manufacturers. The company focuses on contract testing and consulting for sterile and non-sterile drug dosage forms and raw materials, including potency, purity, sterility, endotoxin, particulate matter, stability studies, method development, validation, and environmental monitoring. Its services are aimed at patient safety, regulatory compliance, compounding quality, and drug product verification rather than development of proprietary therapeutics. Dynalabs has also been associated with medication-diversion monitoring initiatives and previously collaborated with Mayo Clinic in launching ANiGENT. The business appears to have operated commercially from St. Louis and was later acquired by Infinity Laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dynalabs.